An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors - Concepedia

Concepedia

Publication | Open Access

An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors

DOI Full Paper Access

66

Citations

41

References

2020

Year

Kirsty Taylor, Helen Loo Yau, Ankur Chakravarthy, Ben Wang, Shu Yi Shen, Ilias Ettayebi, Charles A. Ishak, Philippe L. Bédard, Albiruni Abdul Razak, Aaron R. Hansen,

Journal for ImmunoTherapy of Cancer

Abstract

NCT02811497.

References

	Year	Citations

Page 1